Primary record
2-Propenamide, 3-(2-butyl-1-(2-(diethylamino)ethyl)-1H-benzimidazol-5-yl)-N-hydroxy-, (2E)-
- 库存
- 9,748 克
- 纯度
- 99.0 %
- CAS
- 929016-96-6
化合物标识与属性
- CAS
- 929016-96-6
- PubChem CID
- 49855250
- SMILES
- CCCCC1=NC2=C(N1CCN(CC)CC)C=CC(=C2)/C=C/C(=O)NO
- Canonical SMILES
- CCCCc1nc2cc(/C=C/C(=O)NO)ccc2n1CCN(CC)CC
名称与同义词
- Pracinostat
- 929016-96-6
- SB939
- Pracinostat (SB939)
- pracinostatum
- SB 939
- Pracinostat [INN]
- Pracinostat-d7
- SB-939
- GPO2JN4UON
- SB939 compound
- SB939,Pracinostat
- UNII-GPO2JN4UON
- Pracinostat(SB939)
- Pracinostat(SB939)?
- SB939 (Pracinostat)
- RefChem:175687
- HDAC Inhibitor SB939
- MFCD17215206
- cc-70
- D0L2UQ
- Ganetespib (STA-9090)
- CHEMBL1851943
- PRACINOSTAT [WHO-DD]
- CHEBI:95071
- MLS006011217
- SCHEMBL833105
- DTXSID00239196
- C20H30N4O2
- GTPL8365
- orb1307242
- SCHEMBL29351549
- DTXCID20161687
- EX-A351
- GLXC-90078
- (E)-3-(2-butyl-1-(2-(diethylamino)ethyl)-1H-benzo[d]imidazol-5-yl)-N-hydroxyacrylamide
- AOB87709
- BCP02073
- ABP000582
- BDBM50105330
- NSC758249
- s1515
- SB 939SB-939
- ZINC43152558
- AKOS027250824
- SB-939, SB939
- ACN-029579
- CCG-264903
- CS-0567
- DB05223
- FP43359
- NSC-758249
- RL05848
- NCGC00263136-04
- AC-33161
- AS-19395
- BC660004
- BP-40071
- CID:49855250
- HY-13322
- QC-10486
- SC-86253
- SMR004702979
- SY240532
- SID:202535654
- AB0008159
- A4095
- FT-0673985
- NS00072511
- SW219429-1
- X7533
- EC-000.2481
- J2.751.412J
- A10830
- W-5687
- A850037
- C557525
- BRD-K86797399-001-04-4
- BRD-K86797399-001-05-1
- Q18344027
- (E)-3-[2-butyl-1-[2-(diethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide
- 2-Propenamide, 3-(2-butyl-1-(2-(diethylamino)ethyl)-1H-benzimidazol-5-yl)-N-hydroxy-, (2E)-
- B0084-286706
- KAEMPFEROL 3-O-.BETA.-D-(6-E-P-COUMAROYLGLUCOSIDE)
- KAEMPFEROL 3-O-BETA-D-(6-E-P-COUMAROYLGLUCOSIDE)
- (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-1,3-benzodiazol-5-yl}-N-hydroxyprop-2-enamide
- 2-Propenamide, 3-[2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl]-N-hydroxy-, (2E)-
- (2E)-3-[2-Butyl-1-[2-(diethylaMino)ethyl]-1H-benziMidazol-5-yl]-N-hydroxy-2-propenaMide
- (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1,3-benzodiazol-5-yl}-N-hydroxyprop-2-enamide
- (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide
- (E)-3-[2-butyl-1-(2-diethylaminoethyl)benzimidazol-5-yl]prop-2-enehydroxamic acid
- (E)-3-[2-Butyl-1-[2-(diethylamino)ethyl]-1H-benzoimidazole-5-yl]-N-hydroxypropeneamide
- (E)-3-[2-Butyl-1-[2-(diethylamino)ethyl]-5-benzimidazolyl]-N-hydroxyacrylamide
- (E)-3-[2-butyl-1-[2-(diethylamino)ethyl]benzimidazol-5-yl]prop-2-enehydroxamic acid
- 3-(2-butyl-1-(2-diethylaminoethyl)-1H-benzoimidazol-5-yl)-N-hydroxyacrylamide-hydrochloride
- (2E)-3-(2-butyl-1-(2-(diethylamino)ethyl)-1H-1,3-benzodiazol-5-yl)-N-hydroxyprop-2-enamide
- (2E)-3-(2-BUTYL-1-(2-(DIMETHYLAMINO)ETHYL)-1H-BENZIMIDAZOL-5-YL)-N-HYDROXYPROP-2-ENAMIDE
- (2E)-3-(2-Butyl-1-[2-(diethylamino)ethyl]-1h-1,3-benzodiazol-5-yl)-n-hydroxyprop-2-enamide
- (2E)-3-{2-Butyl-1-[2-(diethylamino)ethyl]-1H-1,3-benzimidazol-5-yl}-N-hydroxyprop-2-enamide
- (E)-3-(2-BUTYL-1-(2-DIETHYLAMINOETHYL)-1H-BENZIMIDAZOL-5-YL)-N-HYDROXY-2-PROPENAMIDE
- 1795137-15-3